Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$498,032
-$51,364 QoQ
Shares Held
3,942
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,373
of 2,265 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026REGATTA CAPITAL GROUP, LLC holds $7,942,018 across 9 Drug Manufacturers - General names. GILD ranks #7 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
7,477 | $2,707,571 | |
| 2 | JNJ |
Johnson & Johnson
|
5,315 | $1,349,850 | |
| 3 | LLY |
ELI LILLY & Co
|
863 | $1,035,108 | |
| 4 | SNY |
Sanofi
|
18,955 | $808,620 | |
| 5 | MRK |
Merck & Co., Inc.
|
4,544 | $583,904 | |
| 6 | NVS |
Novartis AG
|
3,273 | $512,944 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
3,942 | $498,032 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,091 | $235,723 |
All Filings in GILD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,032 | 3,942 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $549,396 | 3,942 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $498,692 | 4,063 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $450,882 | 4,062 | Shares | Sole | 2025-10-17 | |
| No filing history on record for this holder in this stock. | ||||||